Avalia Immunotherapies Overview
- Year Founded
-
2015

- Status
-
Out of Business
- Employees
-
3

- Latest Deal Type
-
Liquidation
Avalia Immunotherapies General Information
Description
Developer of immune system modulators designed to support cancer treatment. The company's modulators help in the treatment of cancer, influenza, allergy, and other diseases and also offer therapeutic vaccines that direct powerful immune cells in the body for targeted responses to disease, enabling healthcare providers to activate immune cells in the patient's body and to improve clinical outcomes for cancer and infectious disease.
Contact Information
Website
www.avaliaimmunotherapies.comCorporate Office
- Gate 7, Victoria University Central Services Building
- Kelburn
- Wellington, 6012
- New Zealand
Corporate Office
- Gate 7, Victoria University Central Services Building
- Kelburn
- Wellington, 6012
- New Zealand
Avalia Immunotherapies Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Bankruptcy: Liquidation | 10-Oct-2023 | Completed | Bankruptcy: Liquidation | |||
5. Later Stage VC | Completed | Pre-Clinical Trials | ||||
4. Grant | 01-May-2020 | Completed | Pre-Clinical Trials | |||
3. Early Stage VC | 10-May-2016 | Completed | Startup | |||
2. Seed Round | $450K | Completed | Startup | |||
1. Accelerator/Incubator | 11-Sep-2015 | $450K | $450K | Completed | Startup |
Avalia Immunotherapies Signals
Avalia Immunotherapies FAQs
-
When was Avalia Immunotherapies founded?
Avalia Immunotherapies was founded in 2015.
-
Where is Avalia Immunotherapies headquartered?
Avalia Immunotherapies is headquartered in Wellington, New Zealand.
-
What is the size of Avalia Immunotherapies?
Avalia Immunotherapies has 3 total employees.
-
What industry is Avalia Immunotherapies in?
Avalia Immunotherapies’s primary industry is Biotechnology.
-
Is Avalia Immunotherapies a private or public company?
Avalia Immunotherapies is a Private company.
-
What is Avalia Immunotherapies’s current revenue?
The current revenue for Avalia Immunotherapies is
. -
How much funding has Avalia Immunotherapies raised over time?
Avalia Immunotherapies has raised $2.52M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »